More Than Meets the Kappa for Antibody Superantigen Protein L (PpL)
Ling, Wei-Li, Yeo, Joshua Yi, Ng, Yuen-Ling, Wipat, Anil, and Gan, Samuel Ken-En (2022) More Than Meets the Kappa for Antibody Superantigen Protein L (PpL). Antibodies, 11 (1). 14.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (6MB) | Preview |
Abstract
Immunoglobulin superantigens play an important role in affinity purification of antibodies and the microbiota-immune axis at mucosal areas. Based on current understanding, Staphylococcal Protein A (SpA), Streptococcal Protein G (SpG) and Finegoldia Protein L (PpL) are thought to only bind specific regions of human antibodies, allowing for selective purification of antibody isotypes and chains. Clinically, these superantigens are often classified as toxins and increase the virulence of the producing pathogen through unspecific interactions with immune proteins. To perform an in-depth interaction study of these three superantigens with antibodies, bio-layer interferometry (BLI) measurements of their interactions with a permutation panel of 63 IgG1 variants of Pertuzumab and Trastuzumab CDRs grafted to the six human Vκ and seven human VH region families were tested. Through this holistic and systemic analysis of IgG1 variants with various antibody regions modified, comparisons revealed novel PpL–antibody interactions influenced by other non-canonical antibody known light-chain framework regions, whereas SpA and SpG showed relatively consistent interactions. These findings have implications on PpL-based affinity antibody purification and design that can guide the engineering and understanding of PpL-based microbiota-immune effects.
Item ID: | 74895 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 2073-4468 |
Keywords: | Pertuzumab; Trastuzumab; IgG1; VH families; VK families; immunoglobulin; superantigen |
Copyright Information: | © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
Date Deposited: | 08 Feb 2023 05:10 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3204 Immunology > 320403 Autoimmunity @ 100% |
SEO Codes: | 20 HEALTH > 2001 Clinical health > 200105 Treatment of human diseases and conditions @ 100% |
Downloads: |
Total: 498 Last 12 Months: 3 |
More Statistics |